We demonstrated that, in contrast to classical opioid receptors, ACKR3 does not trigger classical G protein signaling and is not modulated because of the classical prescription or analgesic opioids, like morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists like naloxone. Rather, we recognized that LIH383, an ACKR3-selective subnanomolar https://ferdinandu013dya6.celticwiki.com/user